tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Akinetic Mutism D000405 1 associated lipids
Albuminuria D000419 18 associated lipids
Alopecia D000505 14 associated lipids
Alopecia Areata D000506 6 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amenorrhea D000568 4 associated lipids
Amputation, Traumatic D000673 2 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Refractory D000753 3 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Aneurysm, Dissecting D000784 2 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Nakagawa K et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. 2015 Am. J. Reprod. Immunol. pmid:25394810
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. 2015 Ann. Intern. Med. pmid:25383607
Farnik H et al. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation. 2015 Liver Int. pmid:24649882
Cantaluppi V et al. Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. 2015 PLoS ONE pmid:26125566
Fukahori H et al. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation. 2015 Int. Immunopharmacol. pmid:26122135
Langone A et al. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study. 2015 Clin Transplant pmid:26113208
Plock JA et al. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. 2015 Transplantation pmid:26102613
Eidens M et al. Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping. 2015 Clin. Lab. pmid:25975003
Castaneda J and Matzuk MM DEVELOPMENTAL BIOLOGY. Toward a rapid and reversible male pill. 2015 Science pmid:26494747
Carenco C et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. 2015 Liver Int. pmid:25488375
Safa K et al. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. 2015 Clin. Nephrol. pmid:24495904
Staatz CE and Tett SE Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients. 2015 Clin Pharmacokinet pmid:26038096
Migita K et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. 2015 Arthritis Res. Ther. pmid:26036592
Yano S et al. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation. 2015 Ann. Hematol. pmid:25325985
Garcia C et al. Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013. 2015 Transplant. Proc. pmid:26036492
Melo MJ et al. Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study. 2015 Transplant. Proc. pmid:26036484
Santos T et al. New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. 2015 Transplant. Proc. pmid:26036483
Miyata H et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive. 2015 Science pmid:26429887
Tanriover B et al. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. 2015 Clin J Am Soc Nephrol pmid:25979971
Meyer C et al. Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. 2015 Clin. Exp. Immunol. pmid:25902927
Sassi MB et al. Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report. 2015 Curr Drug Saf pmid:25968921
Bifano M et al. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects. 2015 Clin Drug Investig pmid:25896946
Wang CY et al. Analysis of tacrolimus blood concentrations in renal transplant patients. 2015 Genet. Mol. Res. pmid:25966149
Caro J et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. 2015 Nephrol. Dial. Transplant. pmid:25274748
Wang L et al. Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. 2015 Genet. Mol. Res. pmid:25966085
Bedi M and Taylor AL Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A. 2015 Cutis pmid:26761940
Colak H et al. Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. 2015 Transplant. Proc. pmid:25964218
Antonini TM et al. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. 2015 AIDS pmid:25387314
Nagaya M et al. A new system to evaluate the influence of immunosuppressive drugs on pancreatic islets using epigenetic analysis in a 3-dimensional culture. 2015 Pancreas pmid:25906448
Wang M et al. Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. 2015 Biomacromolecules pmid:25714622
Gallon L et al. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. 2015 Transplantation pmid:25905982
Chen KH et al. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor. 2015 J. Formos. Med. Assoc. pmid:25843527
Berro M et al. Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality. 2015 Medicina (B Aires) pmid:26339873
Gajzlerska W et al. Use of three-carbon chain compounds as biosynthesis precursors to enhance tacrolimus production in Streptomyces tsukubaensis. 2015 N Biotechnol pmid:25152525
Robertsen I et al. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. 2015 Transplantation pmid:25148382
Yu Z et al. IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. 2015 Mol Med Rep pmid:25333459
Selk A A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus. 2015 J Low Genit Tract Dis pmid:25853633
Hurst AL et al. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients. 2015 Pediatr Transplant pmid:25850753
Tajdaran K et al. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). 2015 Biotechnol. Bioeng. pmid:25850693
Jacobo-Cabral CO et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. 2015 Br J Clin Pharmacol pmid:25846845
Wang L et al. Gq signaling causes glomerular injury by activating TRPC6. 2015 J. Clin. Invest. pmid:25844902
Legendre L et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. 2015 J. Am. Acad. Dermatol. pmid:25840730
Bowman LJ et al. Tacrolimus-Induced Cardiomyopathy in an Adult Renal Transplant Recipient. 2015 Pharmacotherapy pmid:26616582
Miguel-Gómez L et al. [Peristomal pyoderma gangrenosum associated with colon cancer]. 2015 Med Clin (Barc) pmid:25659860
Aouam K et al. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase. 2015 Pharmacogenomics pmid:26615671
Romanowski M et al. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Pharmacogenomics pmid:26282401
Girdlestone J et al. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs. 2015 Cytotherapy pmid:26276002
Suzuki N et al. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. 2015 PLoS ONE pmid:25790231
Ross A and Kirsner RS JID VisualDx Quiz: April 2015. 2015 J. Invest. Dermatol. pmid:25785952
Tavira B et al. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: a Next Generation Sequencing approach. 2015 Clin. Chem. Lab. Med. pmid:25781547
Heneberg P et al. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro. 2015 PLoS ONE pmid:26562153
Plischke M et al. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. 2015 PLoS ONE pmid:26270340
Yang CJ et al. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes. 2015 Biochemistry pmid:26561008
Chen F et al. [Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria]. 2015 Zhonghua Xue Ye Xue Za Zhi pmid:26759101
Fan J et al. Donor IL-18 rs5744247 polymorphism as a new biomarker of tacrolimus elimination in Chinese liver transplant patients during the early post-transplantation period: results from two cohort studies. 2015 Pharmacogenomics pmid:25712187
Morales E et al. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab. 2015 Transpl. Int. pmid:25712140
Buschow SI et al. To target or not to target viral antigens in HBV related HCC? 2015 J. Hepatol. pmid:25711422
Jia N et al. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. 2015 BMC Cancer pmid:26197890
Duong SQ et al. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients. 2015 Pediatr Transplant pmid:26497983
Kawano N et al. Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus. 2015 J Clin Exp Hematop pmid:26490521
Jóźwiak-Bębenista M et al. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation. 2015 Pharmacol Rep pmid:25712659
Pucci N et al. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. 2015 Pediatr Allergy Immunol pmid:25712437
Kim KW et al. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. 2015 Immunology pmid:24974886
Yessayan L et al. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation. 2015 Transplant. Proc. pmid:26707323
Yoon NY et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. 2015 Arch. Dermatol. Res. pmid:25786383
Tanaka M et al. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. 2015 Mult. Scler. pmid:25662352
Van der Perren A et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. 2015 Neurobiol. Aging pmid:25660193
Ayala E et al. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma. 2015 Clin Lymphoma Myeloma Leuk pmid:25659459
Wu SC et al. Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing. 2015 Dis. Markers pmid:26435568
Stefanović NZ et al. Potential role of tacrolimus in erythrocytes' antioxidative capacity in long-term period after renal transplantation. 2015 Eur J Pharm Sci pmid:25657088
Petruzzo P et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. 2015 Ann. Surg. pmid:24646555
Polańska A et al. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography. 2015 Skin Res Technol pmid:24894324
Okechuku G et al. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. 2015 Pediatr Transplant pmid:25661468
Kume K et al. Screening for a gene deletion mutant whose temperature sensitivity is suppressed by FK506 in budding yeast and its application for a positive screening for drugs inhibiting calcineurin. 2015 Biosci. Biotechnol. Biochem. pmid:25614218
Garnock-Jones KP Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. 2015 Drugs pmid:25613762
Li CJ and Li L Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use. 2015 Drug Des Devel Ther pmid:25609922
Uemoto S et al. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients. 2015 Clin. Exp. Immunol. pmid:25603847
Oda K et al. In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure. 2015 Biopharm Drug Dispos pmid:25600613
Overk CR et al. Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506. 2015 Neuroscience pmid:26341908
de Jonge H et al. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. 2015 Br J Clin Pharmacol pmid:26114223
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Rojas-Vega L et al. Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort. 2015 Am. J. Physiol. Renal Physiol. pmid:26336164
Sánchez-Lázaro I et al. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation. 2015 Pharmacogenomics pmid:26107754
Teixeira Mdo C et al. Influence of post-transplant immunosuppressive therapy on gastrointestinal transit using biomagnetic method: a pilot study. 2015 Dig. Dis. Sci. pmid:25146844
Schnitzbauer AA et al. Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. 2015 Ann. Transplant. pmid:25553853
Urquhart BL and Knauer MJ Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients. 2015 Pediatr Transplant pmid:25546506
Aruch DB and Renteria A Simultaneous PRES and TMA secondary to tacrolimus after allogeneic bone marrow transplant. 2015 Blood pmid:26287041
Minami-Hori M et al. Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone. 2015 J. Dermatol. pmid:25544984
Pagliarello C et al. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison. 2015 Eur J Dermatol pmid:25786341
Xing J et al. Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients. 2015 Eur. J. Clin. Pharmacol. pmid:25487141
Gong N et al. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients. 2015 Cell. Immunol. pmid:26205091
Chamani G et al. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. 2015 Int. J. Dermatol. pmid:26204904
Muduma G et al. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK. 2015 J Med Econ pmid:26201252
Mizuno K et al. Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model. 2015 J. Dermatol. Sci. pmid:26198442
Niioka T et al. Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. 2015 Xenobiotica pmid:26189776
Rathi M et al. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. 2015 Transplant. Proc. pmid:26036543
Mohsin N et al. Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. 2015 Transplant. Proc. pmid:26036534
Türkoğlu O et al. Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? 2015 Arch. Oral Biol. pmid:25555253
Rivinius R et al. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. 2015 Drug Des Devel Ther pmid:25552900
Cilião HL et al. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells. 2015 Exp. Toxicol. Pathol. pmid:25541063